Cargando…
Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder
Bladder pathologies, very common in the aged population, have a considerable negative impact on quality of life. Novel targets are needed to design drugs and combinations to treat diseases such as overactive bladder and bladder cancers. A promising new target is the ubiquitous Rho GTPase Rac1, frequ...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219850/ https://www.ncbi.nlm.nih.gov/pubmed/35740379 http://dx.doi.org/10.3390/biomedicines10061357 |